0812 GMT - RELX's performance update is reassuring, Baader analyst Alexandre Desprez writes in a research note. The reduction in federal funding for research seems to have no visible impact on the group, the analyst notes. The information-and-analytics company reported strong growth in article submissions at its scientific, technical and medical division. This will likely alleviate investors' concerns about the group's research segment, Desprez says. Shares are up 0.5% at 3,963 pence. (najat.kantouar@wsj.com)
(END) Dow Jones Newswires
April 24, 2025 04:12 ET (08:12 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.